Press & Media
-
Business Development and Corporate Strategy for Alternative Investment Managers
What do institutional investors expect from smaller managers in a Covid-stricken world?
-
Managed Futures Get Pandemic Market Boost
Will summer inflows into Managed Futures persist through YE 2020?
-
Risk Premia Gets Crushed
Is Risk Premia’s 2020 underperformance year-to-date new? Or more of the same?
-
Hedge Funds Missed Out as Small Vaccine Companies Surged
Generally, hedge funds have had limited exposure to SMID COVID-19 vaccine developer stocks. Is this a missed opportunity, or a measured show of restraint?
-
One of the Best Market Neutral Funds Is Run by a Robot
How have market neutral funds employing AI and machine learning held up in the first half of 2020?
-
Marshall Wace, Welton, Brahman Fire Up New ESG Hedge Funds
ESG remains a “hot” topic in the hedge fund space thus far in 2020, with big-name firms launching numerous vehicles this year alone.
-
The COVID-19 Crisis Could Launch a Wave of New Asset Managers
2020 was set to be a big year for hedge fund launches. Has COVID-19 changed that entirely?
-
These ‘Goldilocks’ tech stocks are defensive plays during coronavirus, but could thrive after too
Has tech become both a growth and a defensive play?
-
Soros Family Office, Texas Pensioners Lead Rush Into Hedge Funds
Is coronavirus-driven market volatility enticing investors back into hedge funds?
-
What Hedge Funds Own – and What It Says About the Market
Does the recent uptick in retail investor activity mirror trades made by hedge fund managers? Or, are Main Street investors a step behind?
